SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMYLIN PHARM.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jbershad who wrote (3)3/7/1996 10:08:00 PM
From: Vladimir   of 52
 
There are some rumors on AMLN managers quiting - go to Web site rumor.html

"Amylin Rumblings....!
Where oh where are those Phase III results from Amylin Pharmaceuticals? The Vice
President of regulatory affairs, Mark Lotz, quit. The President and CTO, Tim Rink,
resigned to (ahmem) "pursue other interests". And, wasn't all of that kept very quiet.
Anonymous Submission (Ed. I contacted Amylin by email about this..through their www site
amylin.com...but received no response)"
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News